Skip to content

Opening book details…

Can I read Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for Treatment of Patients With Acute Severe Hypertension on EtoBox?

Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for Treatment of Patients With Acute Severe Hypertension by Tyler W. Barrett; David L. Schriger is a Medicine article available to read on EtoBox.

What is Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for Treatment of Patients With Acute Severe Hypertension about?

What is already known on this topic: Most intravenous agents used to acutely lower blood pressure have problems with safety characteristics, and some require continuous direct arterial monitoring during use. What question this study addressed: This study examined the safety and efficacy of intravenous clevidipine, an investigational drug, in an open-label convenience sample of 126 patients with severe hypertension. What this study adds to our knowledge: Blood pressure was quickly decreased in most patients to target range using a non-weight-based dosing of intravenous clevidipine. Further titration of blood pressure by continuous infusion was safely achieved with simple blood pressure cuff monitoring.

Who reads Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for Treatment of Patients With Acute Severe Hypertension?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Tyler W. Barrett; David L. Schriger
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6760)
Published
2009
Language
EN
Field
Medicine (Health Sciences)

More by Tyler W. Barrett; David L. Schriger

Browse all works by Tyler W. Barrett; David L. Schriger